IP Library Granted Patent US 11,877,989
Granted Patent B2
US 11,877,989 · App. 17/346,621 · Granted Jan 23, 2024

Nutritional supplement containing L-α-glycerophosphorylcholine

Inventors: Liangxi Li (Plantation, FL); John H. Owoc (Southwest Ranches, FL)
Assignee: Energy Beverages LLC
A61K31/14A23L2/52A23L33/30A61K9/0095A61K31/197A61K31/522A61K31/661A61K36/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,877,989
App. No.
17/346,621
Granted
Jan 23, 2024
Kind
B2
Abstract

A nutritional supplement contains 50% to 80% by weight of trimethylglycine; 5% to 30% by weight of L-α-glycerophosphorylcholine; 5% to 15% by weight of caffeine; and 5% to 10% by weight of an ingredient selected from the group consisting of an L-amino acid, creatyl-L-leucine, Corynanthe yohimbe bark extract, theacrine, and mixtures thereof. The nutritional supplement is useful for enhancing energy, mental acuity, cognitive performance, and reaction time in a subject in need thereof.

Claims (21)

1. A nutritional supplement, comprising:

a. 50% to 80% by weight of trimethylglycine;

b. 5% to 30% by weight of L-α-glycerophosphorylcholine or a precursor thereof, wherein the precursor is phosphatidylethanolamine, phosphatidylcholine, or citicoline;

c. 5% to 15% by weight of caffeine; and

d. 5% to 10% by weight of an ingredient selected from the group consisting of an L-amino acid, creatyl-L-leucine, Corynanthe yohimbe bark extract, theacrine, and mixtures thereof.

2. The nutritional supplement of claim 1 , wherein the ingredient contains creatyl-L-leucine.

3. The nutritional supplement of claim 1 , wherein the ingredient contains an L-amino acid selected from the group consisting of asparagine, glutamine, aspartic acid, glutamic acid, theanine, and combination thereof.

4. The nutritional supplement of claim 3 wherein the L-amino acid is L-theanine.

5. The nutritional supplement of claim 1 , wherein the ingredient contains an L-amino acid selected from the group consisting of N-alkyl derivatives of asparagine, N-alkyl derivatives of glutamine, and combination thereof.

6. The nutritional supplement of claim 5 , wherein the ingredient contains N 5 -ethyl-L-glutamine.

7. The nutritional supplement of claim 1 , wherein the nutritional supplement comprises 60% to 75% by weight of trimethylglycine and 10% to 20% by weight of L-α-glycerophosphorylcholine.

8. A dosage form comprising the nutritional supplement of claim 1 and a carrier.

9. The dosage form of claim 8 , wherein the dosage form is a tablet, a capsule, a syrup, an emulsion, a dispersion, a candy, a liquid shot, a carbonated beverage, or a non-carbonated beverage.

10. The dosage form of claim 8 , wherein the carrier is a liquid carrier or a solid carrier.

11. The dosage form of claim 8 , wherein the dosage form is a beverage, and the carrier is a carbonated or non-carbonated aqueous carrier.

12. A method of enhancing energy, mental acuity, cognitive performance, and reaction time in a subject in need thereof, comprising administering an effective amount of the nutritional supplement of claim 11 to the subject.

13. The method of claim 12 wherein the effective amount of the nutritional supplement ranges from 1,500 mg/dose to 8,000 mg/dose, based on the total weight of the nutritional supplement.

14. The method of claim 12 , wherein the effective amount of the nutritional supplement is sufficient to provide the subject with L-α-glycerophosphorylcholine in an amount ranging from 100 mg/dose to 1,875 mg/dose.

15. A method of enhancing pattern recognition skills and reaction time in a subject in need thereof, comprising administering an effective amount of the nutritional supplement of claim 1 to the subject.

16. The method of claim 15 wherein the effective amount of the nutritional supplement ranges from 1,500 mg/dose to 8,000 mg/dose, based on the total weight of the nutritional supplement.

17. The method of claim 16 , wherein the effective amount of the nutritional supplement is sufficient to provide the subject with L-α-glycerophosphorylcholine in an amount ranging from 100 mg/dose to 1,875 mg/dose.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2023
From: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
To: VITAL PHARMACEUTICALS, INC.
Reel/Frame 065335/0726 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2023
From: VITAL PHARMACEUTICALS, INC.; VITAL PHARMACEUTICALS INTERNATIONAL SALES, INC.
To: ENERGY BEVERAGES LLC
Reel/Frame 065336/0001 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 8, 2022
From: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
To: TRUIST BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 059350/0992 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT APPLICATION NUMBER 62/167359 CORRECTED TO 63/167359 PREVIOUSLY RECORDED AT REEL: 058339 FRAME: 0676. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 16, 2021
From: ELITE IP HOLDINGS, LLC
To: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
Reel/Frame 058742/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2021
From: ELITE IP HOLDINGS, LLC
To: JHO INTELLECTUAL PROPERTY HOLDINGS, LLC
Reel/Frame 058339/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2021
From: LI, LIANGXI; OWOC, JOHN H.
To: ELITE IP HOLDINGS, LLC
Reel/Frame 056533/0126 →